Back to companies

SyntekaBio,Inc.

226330KRKRX

신테카바이오

Revenue
₩120.9mn
FY2024
Operating income
-₩14.3bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)